CDSAF yields 5.53% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, CDSAF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CDSAF + MRK for your $10,000?
Cydsa, S.A.B. de C.V., together its subsidiaries, engages in the production and marketing of salt, chlorine, caustic soda, and refrigerant gases in Mexico, the United States, Canada, Central and South America, Asia, and Europe. It operates through Salt, Chlorine and Caustic Soda, Refrigerant Gases, and Energy Processing and Logistics segments. The company offers light salt, salt substitute, Kosher and halal grade salt, salt with chili and lime, and coarse sea salt for use in household and commercial human consumption, food industry, and industrial processes. It also provides chlorine, liquid and gas, chlorine in cylinders, sodium hypochlorite, caustic potash, synthetic hydrochloric acid, and muriatic acid, as well as liquid, solid, and rayon and membrane grade caustic soda for use in chemical and petrochemical industries, water treatment, oils, cellulose, papers, bottling, pesticides, bleaches, detergents and soaps, plastics, pigments, paints, and mining and extraction of metals. In addition, the company offers refrigerant, propellant, and blowing gases, as well as gases for fluoropolymers and anesthetic medical products for use in industrial, commercial and domestic refrigeration, home appliances, and pharmaceutical industries. Further, it is involved in the electricity and steam cogeneration business; and hydrocarbons processing and underground storage business, as well as provides liquid petroleum gas storage services. The company offers its products under the La Fina, Cisne, Marfil, Gallo, Palomitos, Bakará, Elefante, Klara, Carmen, Brisa de Occidente, Genetron, Aquion, and Eco Flush trademarks. Cydsa, S.A.B. de C.V. was founded in 1945 and is headquartered in Monterrey, Mexico.
Full CDSAF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.